UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The European respiratory journal, ISSN 0903-1936, 07/2013, Volume 42, Issue 1, pp. 239 - 251
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Bronchiectasis - drug therapy | Macrolides - administration & dosage | Bronchiolitis - drug therapy | Humans | Respiratory Tract Infections - drug therapy | Clinical Trials as Topic | Asthma - drug therapy | Anti-Bacterial Agents - therapeutic use | Pneumonia - drug therapy | Bronchiolitis Obliterans - drug therapy | Macrolides - therapeutic use | Anti-Bacterial Agents - administration & dosage | Chronic Disease | Cystic Fibrosis - drug therapy | Haemophilus Infections - drug therapy | Sinusitis - drug therapy | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2012, Volume 185, Issue 1, pp. 12 - 23
Corticosteroids | Treatment | Respiratory system | Lung | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Emergency and intensive respiratory care | Bronchopulmonary Dysplasia - drug therapy | Bronchiolitis - drug therapy | Croup - drug therapy | Humans | Child, Preschool | Infant | Treatment Outcome | Adrenal Cortex Hormones - therapeutic use | Lung Diseases - drug therapy | Respiratory Distress Syndrome, Adult - drug therapy | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Asthma - drug therapy | Pediatrics - methods | Tuberculosis - drug therapy | Respiratory Sounds - drug effects | Child | Cystic Fibrosis - drug therapy | Infant, Newborn | Index Medicus | Abridged Index Medicus
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 03/2008, Volume 117, Issue 3, pp. 393 - 405
Diffuse panbronchiolitis | Macrolide antibiotics | Cystic fibrosis | Extracellular signal-regulated MAP kinases | Cytokines | Asthma | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Humans | Inflammatory Bowel Diseases - immunology | Bronchiolitis - immunology | Bone Remodeling - drug effects | Rhinitis - drug therapy | Anti-Bacterial Agents - therapeutic use | Sinusitis - immunology | Asthma - immunology | Arthritis - immunology | Macrolides - pharmacology | Inflammatory Bowel Diseases - drug therapy | Rhinitis - immunology | Bronchiolitis - drug therapy | Bone Resorption - drug therapy | Skin Diseases - drug therapy | Skin Diseases - immunology | Bone Resorption - immunology | Asthma - drug therapy | Connective Tissue Diseases - immunology | Animals | Connective Tissue Diseases - drug therapy | Arthritis - drug therapy | Anti-Bacterial Agents - pharmacology | Macrolides - therapeutic use | Immunologic Factors - pharmacology | Sinusitis - drug therapy | Immunologic Factors - therapeutic use | Index Medicus
Journal Article
The Journal of pediatrics, ISSN 0022-3476, 2012, Volume 161, Issue 6, pp. 1104 - 1108
Pediatrics | LOS | Respiratory syncytial virus | Length of stay in hospital | RSV | Acute viral bronchiolitis | Interleukin | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchiolitis, Viral - diagnosis | Humans | Infant | Male | Paramyxoviridae Infections - diagnosis | Respiratory Syncytial Virus Infections - drug therapy | Anti-Inflammatory Agents - therapeutic use | Female | Influenza, Human - diagnosis | Influenza, Human - drug therapy | Influenza, Human - therapy | Bronchiolitis, Viral - drug therapy | Infant, Newborn | Length of Stay - statistics & numerical data | Acute Disease | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Paramyxoviridae Infections - therapy | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Hospitalization | Oxygen Inhalation Therapy | Respiratory Syncytial Virus Infections - diagnosis | Azithromycin - therapeutic use | Bronchiolitis, Viral - therapy | Paramyxoviridae Infections - drug therapy | Respiratory Syncytial Virus Infections - therapy | Clinical trials | Infants | Patient outcomes | Azithromycin | Bronchiolitis | Index Medicus | Abridged Index Medicus
Journal Article
Thorax, ISSN 0040-6376, 05/2015, Volume 70, Issue 5, pp. 442 - 450
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Double-Blind Method | Bronchiolitis Obliterans - etiology | Humans | Middle Aged | Male | Treatment Outcome | Lung Transplantation - adverse effects | Syndrome | Bronchiolitis Obliterans - diagnosis | Forced Expiratory Volume | Anti-Bacterial Agents - therapeutic use | Azithromycin - therapeutic use | Adult | Female | Bronchiolitis Obliterans - drug therapy | Clinical trials | Usage | Care and treatment | Dosage and administration | Azithromycin | Bronchiolitis | Studies | Clinical medicine | Transplants & implants | Drug dosages | Mortality | Neutrophils | Index Medicus | 1506 | Lung Transplantation
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 07/2003, Volume 168, Issue 1, pp. 121 - 125
Chronic rejection | Macrolides | Obliterative bronchiolitis | Lung transplant | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Follow-Up Studies | Forced Expiratory Volume - drug effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Azithromycin - immunology | Anti-Bacterial Agents - therapeutic use | Cystic Fibrosis - surgery | Time Factors | Adult | Severity of Illness Index | Drug Administration Schedule | Administration, Oral | Bronchiolitis Obliterans - etiology | Treatment Outcome | Bronchiectasis - surgery | Lung Transplantation - adverse effects | Syndrome | Azithromycin - pharmacology | Bronchiolitis Obliterans - diagnosis | Pulmonary Fibrosis - surgery | Pilot Projects | Anti-Bacterial Agents - immunology | Azithromycin - therapeutic use | Quality of Life | Anti-Bacterial Agents - pharmacology | Bronchiolitis Obliterans - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 02/2011, Volume 183, Issue 4, pp. 531 - 538
Viral pneumonia | Antiviral therapy | Bronchiolitis obliterans | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Emergency and intensive respiratory care | RNA Interference - drug effects | Double-Blind Method | Follow-Up Studies | Antiviral Agents - therapeutic use | Humans | Administration, Inhalation | Treatment Outcome | Reverse Transcriptase Polymerase Chain Reaction | Bronchiolitis Obliterans - complications | Syndrome | Bronchiolitis Obliterans - prevention & control | Young Adult | Lung Transplantation | Cytokines - drug effects | RNA, Small Interfering - therapeutic use | Respiratory Syncytial Virus Infections - blood | Adolescent | C-Reactive Protein - drug effects | Respiratory Function Tests | Respiratory Syncytial Virus Infections - therapy | Respiratory Syncytial Virus Infections - complications | Cytokines - blood | Index Medicus | Abridged Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2014, Volume 58, Issue 3, pp. 1451 - 1457
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | United States - epidemiology | Acute Disease | Age Factors | Bronchiolitis - drug therapy | Humans | Middle Aged | Inappropriate Prescribing - statistics & numerical data | Child, Preschool | Male | Respiratory Tract Infections - drug therapy | Emergency Service, Hospital - statistics & numerical data | Young Adult | Anti-Bacterial Agents - therapeutic use | Bronchitis - drug therapy | Adolescent | Pharyngitis - drug therapy | Adult | Female | Pneumonia, Bacterial - drug therapy | Aged | Retrospective Studies | Child | Health Care Surveys | Index Medicus | Epidemiology and Surveillance
Journal Article
American journal of transplantation, ISSN 1600-6135, 01/2016, Volume 16, Issue 1, pp. 254 - 261
lung | preventive healthcare | bronchiolitis obliterans (BOS) | (allograft) function/dysfunction | clinical research/practice | lung transplantation/pulmonology | rejection: chronic | lung failure/injury | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Graft Rejection - drug therapy | Prognosis | Double-Blind Method | Follow-Up Studies | Humans | Risk Factors | Bacteremia - drug therapy | Graft Rejection - etiology | Graft Survival | Male | Antibiotic Prophylaxis | Bronchiolitis Obliterans - surgery | Bronchiolitis Obliterans - complications | Lung Transplantation - adverse effects | Syndrome | Transplantation, Homologous | Bacteremia - microbiology | Forced Expiratory Volume | Anti-Bacterial Agents - therapeutic use | Azithromycin - therapeutic use | Female | Graft Rejection - pathology | Postoperative Complications | Cohort Studies | Lung diseases, Obstructive | Analysis | Mortality | Azithromycin | Clinical trials | Transplantation of organs, tissues, etc | Mycophenolate mofetil | Drug therapy | Medicine, Preventive | Preventive health services | Index Medicus
Journal Article